Yi Cui

Effect of CYP2D6, CYP3A5, and MDR1 Genetic Polymorphisms on the Pharmacokinetics of Risperidone and Its Active Moiety

Qian Xiang, Xia Zhao, Ying Zhou et al. · The Journal of Clinical Pharmacology · 2010 · 92 citations

Molecular Pharmacology, Mdr1 Genetic Polymorphisms, Genetics +14

Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele

Yi Cui, Choo Hua Teng, Alan X. Pan et al. · British Journal of Clinical Pharmacology · 2007 · 40 citations · Full text

Pharmacokinetics, Safety, and Tolerability of Single‐ and Multiple‐Dose Once‐Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo‐Controlled Study

Xia Zhao, Xiao Sheng, Christopher D. Payne et al. · Clinical Pharmacology in Drug Development · 2020 · 20 citations · Full text

Pharmacokinetics, safety, and tolerability of single‐ and multiple‐dose exenatide once weekly in <scp>C</scp>hinese patients with type 2 diabetes mellitus (对中国2型糖尿病患者单次和多次给予艾塞那肽周制剂的药代动力学、安全性和耐受性研究)

Yi Cui, Xiao Hui Guo, Dong Mei Zhang et al. · Journal of Diabetes · 2013 · 19 citations

The Influence of &lt;i&gt;MDR1 G2677T/A&lt;/i&gt; Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers

Qian Xiang, Yi Cui, Xia Zhao et al. · Pharmacology · 2012 · 18 citations